Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1)

Brain Research

Volumn 1106, Issue 1, 2006, Pages 205-210

  Kapoor, Ranjna ^a   Lim, Kelly SY ^a   Cheng, Alice ^a   Garrick, Therese ^b   Kapoor, Vimal ^a  

^a University of Sydney   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

DAAO; Gene expression; KAT 1; NMDA; Schizophrenia

Indexed keywords

DEXTRO AMINO ACID OXIDASE; ENZYME; GLYCINE RECEPTOR; KYNURENINE AMINOTRANSFERASE; LIGAND; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN; CEREBELLUM; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA;

ALTERNATIVE SPLICING; ANIMALS; CEREBELLUM; D-AMINO-ACID OXIDASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIGANDS; MODELS, NEUROLOGICAL; PARIETAL LOBE; PROTEIN ISOFORMS; RATS; RATS, INBRED WKY; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; TRANSAMINASES; UP-REGULATION;

EID: 33746813128     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.05.082     Document Type: Article

References (37)

1. Avila M.T., Martin A., Weiler M.A., Lahti A.C., Tamminga C.A., and Thaker G.K. Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia. American Journal of Psychiatry (2002) 159
2. Bara H., Hainfellner J.A., Kepplinger B., Mazal P.R., Schmid H., and Budka H. Kynurenic acid metabolism in the brain of HIV-1 infected patients. J. Neural Transm. 107 (2000) 1127-1138
3. Baran H., Jellinger K., and Deecke L. Kynurenine metabolism in Alzheimer's disease. J. Neural Transm. 106 (1999) 165-181
4. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., Bougueleret L., Barry C., Tanaka H., La Rosa P., Puech A., Tahri N., Cohen-Akenine A., Delabrosse S., Lissarrague S., Picard F.P., Maurice K., Essioux L., Millasseau P., Grel P., Debailleul V., Simon A.M., Caterina D., Dufaure I., Malekzadeh K., Belova M., Luan J.J., Bouillot M., Sambucy J.L., Primas G., Saumier M., Boubkiri N., Martin-Saumier S., Nasroune M., Peixoto H., Delaye A., Pinchot V., Bastucci M., Guillou S., Chevillon M., Sainz-Fuertes R., Meguenni S., Aurich-Costa J., Cherif D., Gimalac A., Van Duijn C., Gauvreau D., Ouellette G., Fortier I., Raelson J., Sherbatich T., Riazanskaia N., Rogaev E., Raeymaekers P., Aerssens J., Konings F., Luyten W., Macciardi F., Sham P.C., Straub R.E., Weinberger D.R., Cohen N., and Cohen D. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13675-13680
5. Cloninger C.R. The discovery of susceptibility genes for mental disorders. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13365-13367
6. De Miranda J., Santoro A., Engelender S., and Wolosker H. Human serine racemase: molecular cloning, genomic organization and functional analysis. Gene 256 (2000) 183-188
7. Dunlop D.S., and Neidle A. The origin and turnover of d-serine in brain. Biochem. Biophys. Res. Commun. 235 (1997) 26-30
8. Erhardt S., Blennow K., Nordin C., Skogh E., Lindstrom L.H., and Engberg G. Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci. Lett. 313 (2001) 96-98
9. Guillemin G.J., Kerr S.J., Smythe G.A., Smith D.G., Kapoor V., Armati P.J., Croitoru J., and Brew B.J. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J. Neurochem. 78 (2001) 842-853
10. Hashimoto A., and Oka T. Free d-aspartate and d-serine in the mammalian brain and periphery. Prog. Neurobiol. 52 (1997) 325-353
11. Hashimoto K., Fukushima T., Shimizu E., Komatsu N., Watanabe H., Shinoda N., Nakazato M., Kumakiri C., Okada S., Hasegawa H., Imai K., and Iyo M. Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia. Arch. Gen. Psychiatry 60 (2003) 572-576
12. Hashimoto K., Engberg G., Shimizu E., Nordin C., Lindstrom L.H., and Iyo M. Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog. Neuro-psychopharmacol. Biol. Psychiatry 29 (2005) 767-769
13. Holcomb H.H., Lahti A.C., Medoff D.R., Weilerand M.A., and Tamminga C.A. Sequential regional cerebral blood flow brain scans using PET with H215O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology 25 (2001) 165-172
14. Horiike K., Tojo H., Arai R., Nozaki M., and Maeda T. d-amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes. Brain Res. 652 (1994) 297-303
15. Kapoor R., and Kapoor V. Distribution of d-amino oxidase (DAO) activity in the medulla and thoracic spinal cord of the rat: implications for a role of d-serine in autonomic function. Brain Res. 771 (1997) 351-355
16. Kapoor V., Kapoor R., and Chalmers J. Kynurenic acid, an endogenous glutamate antagonist, in SHR and WKY rats: possible role in central blood pressure regulation. Clin. Exp. Pharmacol. Physiol. 21 (1994) 891-896
17. Konno R. Rat d-amino-acid oxidase cDNA: rat d-amino-acid oxidase as an intermediate form between mouse and other mammalian d-amino-acid oxidases. Biochim. Biophys. Acta 1395 (1998) 165-170
18. Konno R. Rat cerebral serine racemase: amino acid deletion and truncation at carboxy terminus. Neurosci. Lett. 349 (2003) 111-114
19. Lederer E.B., Bastani K., and Goebel F.D. A new quantitative RT-PCR assay for the vasoconstrictor endothelin. Res. Exp. Med. (Berl) 196 (1996) 77-86
20. Ma J., Qin W., Wang X.Y., Guo T.W., Bian L., Duan S.W., Li X.W., Zou F.G., Fang Y.R., Fang J.X., Feng G.Y., Gu N.F., St Clair D., and He L. Further evidence for the association between G72/G30 genes and schizophrenia in two ethnically distinct populations. Mol. Psychiatry 11 (2006) 479-487
21. Miller R.F. d-Serine as a glial modulator of nerve cells. Glia 47 (2004) 275-283
22. Moreno S., Nardacci R., Cimini A., and Ceru M.P. Immunocytochemical localization of d-amino acid oxidase in rat brain. J. Neurocytol. 28 (1999) 169-185
23. Mosca M., Croci C., Mostardini M., Breton J., Malyszko J., Avanzi N., Toma S., Benatti L., and Gatti S. Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Biochim. Biophys. Acta 1628 (2003) 1-10
24. Olney J.W., Newcomer J.W., and Farber N.B. NMDA receptor hypofunction model of schizophrenia. J. Psychiatr. Res. 33 (1999) 523-533
25. Schell M.J. The N-methyl d-aspartate receptor glycine site and d-serine metabolism: an evolutionary perspective. Philos. Trans R. Soc. Lond., B. Biol. Sci. 359 (2004) 943-964
26. Schell M.J., Molliver M.E., and Snyder S.H. d-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3948-3952
27. Schumacher J., Jamra R.A., Freudenberg J., Becker T., Ohlraun S., Otte A.C., Tullius M., Kovalenko S., Bogaert A.V., Maier W., Rietschel M., Propping P., Nothen M.M., and Cichon S. Examination of G72 and d-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol. Psychiatry 9 (2004) 203-207
28. Schwarcz R., Rassoulpour A., Wu H.Q., Medoff D., Tamminga C.A., and Roberts R.C. Increased cortical kynurenate content in schizophrenia. Biol. Psychiatry 50 (2001) 521-530
29. Stone T.W., and Darlington L.G. Endogenous kynurenines as targets for drug discovery and development. Nat. Rev., Drug Discov. 1 (2002) 609-620
30. Swartz K.J., During M.J., Freese A., and Beal M.F. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J. Neurosci. 10 (1990) 2965-2973
31. Urai Y., Jinnouchi O., Kwak K.T., Suzue A., Nagahiro S., and Fukui K. Gene expression of d-amino acid oxidase in cultured rat astrocytes: regional and cell type specific expression. Neurosci. Lett. 324 (2002) 101-104
32. Wang Z., and Zhu X.Z. Spatiotemporal relationships among d-serine, serine racemase and d-amino acid oxidase during mouse postnatal development. Acta Pharmacol. Sin. 24 (2003) 965-974
33. Watanabe T., Motomura Y., and Suga T. A new colorimetric determination of d-amino acid oxidase and urate oxidase activity. Anal. Biochem. 86 (1978) 310-315
34. Weiser M., Davidson M., and Noy S. Comments on risk for schizophrenia. Schizophr. Res. 79 (2005) 15-21
35. Wolosker H., Blackshaw S., and Snyder S.H. Serine racemase: a glial enzyme synthesizing d-serine to regulate glutamate-N-methyl-d-aspartate neurotransmission. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13409-13414
36. Xia M., Liu Y., Figueroa D.J., Chiu C.S., Wei N., Lawlor A.M., Lu P., Sur C., Koblan K.S., and Connolly T.M. Characterization and localization of a human serine racemase. Brain Res. Mol. Brain Res. 125 (2004) 96-104
37. Yamada K., Ohnishi T., Hashimoto K., Ohba H., Iwayama-Shigeno Y., Toyoshima M., Okuno A., Takao H., Toyota T., Minabe Y., Nakamura K., Shimizu E., Itokawa M., Mori N., Iyo M., and Yoshikawa T. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels. Biol. Psychiatry 57 (2005) 1493-1503